An excellent response to therapy resulted in a significant decrease in the likelihood of thyroid cancer recurrence: from 25% to 5.3% in high-risk patients and from 23.7% to 3.6% in patients with postoperative s-Tg ≥ 10 ng/mL. Here, TG is linked to thyroid cancer.